OraSure Technologies to Present at Stephens 2019 Nashville Investment Conference
November 06 2019 - 6:00AM
OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in
point-of-care diagnostic tests and specimen collection devices,
today announced that Dr. Stephen S. Tang, President and CEO, and
Mr. Roberto Cuca, Chief Financial Officer will host a fireside chat
with the investment community at the Stephens 2019 Nashville
Investment Conference. The conference will be simultaneously
webcast over the Internet.
Dr. Tang and Mr. Cuca are scheduled to speak on
Wednesday, November 13, 2019, at approximately 9:15 AM Eastern Time
(8:15 AM Central Time / 6:15 AM Pacific Time). Interested
investors can access the live webcast of the presentation by going
to OraSure Technologies’ web site, www.orasure.com and clicking on
the Investors link. A replay of the webcast will be available
on OraSure Technologies’ web site for seven days.
Alternatively, you can access the live webcast of the presentation
via the following link:
http://wsw.com/webcast/stph31/osur/
About OraSure
Technologies
OraSure Technologies is empowering the global
community to improve health and wellness by providing access to
accurate essential information. OraSure is a leader in the
development, manufacture and distribution of point-of-care
diagnostic tests, molecular collection devices and other
technologies designed to detect or diagnose critical medical
conditions. Its first-to-market, innovative products include rapid
tests for the detection of antibodies to HIV and Hepatitis C (HCV)
on the OraQuick® platform, sample self-collection and stabilization
products for molecular applications, and oral fluid laboratory
tests for detecting various drugs of abuse. Together with its
wholly-owned subsidiaries (DNA Genotek, CoreBiome and Novosanis),
OraSure provides its customers with value-added, end-to-end
solutions that encompass tools, diagnostics and services.
OraSure’s portfolio of products is sold globally to various
clinical laboratories, hospitals, clinics, community-based
organizations and other public health organizations, research
institutions, distributors, government agencies, physicians’
offices, commercial and industrial entities and consumers. For more
information on OraSure Technologies, please visit
www.orasure.com.
Company contact:
Roberto Cuca |
Jeanne Mell |
Chief Financial Officer |
VP Corporate Communications |
610-882-1820 |
484-353-1575 |
Investorinfo@orasure.com |
media@orasure.com |
www.orasure.com |
www.orasure.com |
OraSure Technologies (NASDAQ:OSUR)
Historical Stock Chart
From Jun 2024 to Jul 2024
OraSure Technologies (NASDAQ:OSUR)
Historical Stock Chart
From Jul 2023 to Jul 2024